Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Primaquine Market Growth 2022-2028

  • LP 4754579
  • 78 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Primaquine will have significant change from previous year. According to our (LP Information) latest study, the global Primaquine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Primaquine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Primaquine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Primaquine market, reaching US$ million by the year 2028. As for the Europe Primaquine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Primaquine players cover Cyper Pharma, Santa Cruz Biotechnology, Pfizer, and Summit Medical Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Primaquine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Injectables Primaquine

Capsules Primaquine

Tablets Primaquine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Laboratory

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Cyper Pharma

Santa Cruz Biotechnology

Pfizer

Summit Medical Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Primaquine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Primaquine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Primaquine by Country/Region, 2017, 2022 & 2028

2.2 Primaquine Segment by Type

2.2.1 Injectables Primaquine

2.2.2 Capsules Primaquine

2.2.3 Tablets Primaquine

2.3 Primaquine Sales by Type

2.3.1 Global Primaquine Sales Market Share by Type (2017-2022)

2.3.2 Global Primaquine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Primaquine Sale Price by Type (2017-2022)

2.4 Primaquine Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Laboratory

2.4.4 Others

2.5 Primaquine Sales by Application

2.5.1 Global Primaquine Sale Market Share by Application (2017-2022)

2.5.2 Global Primaquine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Primaquine Sale Price by Application (2017-2022)

3 Global Primaquine by Company

3.1 Global Primaquine Breakdown Data by Company

3.1.1 Global Primaquine Annual Sales by Company (2020-2022)

3.1.2 Global Primaquine Sales Market Share by Company (2020-2022)

3.2 Global Primaquine Annual Revenue by Company (2020-2022)

3.2.1 Global Primaquine Revenue by Company (2020-2022)

3.2.2 Global Primaquine Revenue Market Share by Company (2020-2022)

3.3 Global Primaquine Sale Price by Company

3.4 Key Manufacturers Primaquine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Primaquine Product Location Distribution

3.4.2 Players Primaquine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Primaquine by Geographic Region

4.1 World Historic Primaquine Market Size by Geographic Region (2017-2022)

4.1.1 Global Primaquine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Primaquine Annual Revenue by Geographic Region

4.2 World Historic Primaquine Market Size by Country/Region (2017-2022)

4.2.1 Global Primaquine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Primaquine Annual Revenue by Country/Region

4.3 Americas Primaquine Sales Growth

4.4 APAC Primaquine Sales Growth

4.5 Europe Primaquine Sales Growth

4.6 Middle East & Africa Primaquine Sales Growth

5 Americas

5.1 Americas Primaquine Sales by Country

5.1.1 Americas Primaquine Sales by Country (2017-2022)

5.1.2 Americas Primaquine Revenue by Country (2017-2022)

5.2 Americas Primaquine Sales by Type

5.3 Americas Primaquine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Primaquine Sales by Region

6.1.1 APAC Primaquine Sales by Region (2017-2022)

6.1.2 APAC Primaquine Revenue by Region (2017-2022)

6.2 APAC Primaquine Sales by Type

6.3 APAC Primaquine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Primaquine by Country

7.1.1 Europe Primaquine Sales by Country (2017-2022)

7.1.2 Europe Primaquine Revenue by Country (2017-2022)

7.2 Europe Primaquine Sales by Type

7.3 Europe Primaquine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Primaquine by Country

8.1.1 Middle East & Africa Primaquine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Primaquine Revenue by Country (2017-2022)

8.2 Middle East & Africa Primaquine Sales by Type

8.3 Middle East & Africa Primaquine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Primaquine

10.3 Manufacturing Process Analysis of Primaquine

10.4 Industry Chain Structure of Primaquine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Primaquine Distributors

11.3 Primaquine Customer

12 World Forecast Review for Primaquine by Geographic Region

12.1 Global Primaquine Market Size Forecast by Region

12.1.1 Global Primaquine Forecast by Region (2023-2028)

12.1.2 Global Primaquine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Primaquine Forecast by Type

12.7 Global Primaquine Forecast by Application

13 Key Players Analysis

13.1 Cyper Pharma

13.1.1 Cyper Pharma Company Information

13.1.2 Cyper Pharma Primaquine Product Offered

13.1.3 Cyper Pharma Primaquine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Cyper Pharma Main Business Overview

13.1.5 Cyper Pharma Latest Developments

13.2 Santa Cruz Biotechnology

13.2.1 Santa Cruz Biotechnology Company Information

13.2.2 Santa Cruz Biotechnology Primaquine Product Offered

13.2.3 Santa Cruz Biotechnology Primaquine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Santa Cruz Biotechnology Main Business Overview

13.2.5 Santa Cruz Biotechnology Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Primaquine Product Offered

13.3.3 Pfizer Primaquine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Summit Medical Group

13.4.1 Summit Medical Group Company Information

13.4.2 Summit Medical Group Primaquine Product Offered

13.4.3 Summit Medical Group Primaquine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Summit Medical Group Main Business Overview

13.4.5 Summit Medical Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Primaquine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Primaquine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Injectables Primaquine

Table 4. Major Players of Capsules Primaquine

Table 5. Major Players of Tablets Primaquine

Table 6. Global Primaquine Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Primaquine Sales Market Share by Type (2017-2022)

Table 8. Global Primaquine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Primaquine Revenue Market Share by Type (2017-2022)

Table 10. Global Primaquine Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Primaquine Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Primaquine Sales Market Share by Application (2017-2022)

Table 13. Global Primaquine Revenue by Application (2017-2022)

Table 14. Global Primaquine Revenue Market Share by Application (2017-2022)

Table 15. Global Primaquine Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Primaquine Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Primaquine Sales Market Share by Company (2020-2022)

Table 18. Global Primaquine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Primaquine Revenue Market Share by Company (2020-2022)

Table 20. Global Primaquine Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Primaquine Producing Area Distribution and Sales Area

Table 22. Players Primaquine Products Offered

Table 23. Primaquine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Primaquine Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Primaquine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Primaquine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Primaquine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Primaquine Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Primaquine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Primaquine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Primaquine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Primaquine Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Primaquine Sales Market Share by Country (2017-2022)

Table 36. Americas Primaquine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Primaquine Revenue Market Share by Country (2017-2022)

Table 38. Americas Primaquine Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Primaquine Sales Market Share by Type (2017-2022)

Table 40. Americas Primaquine Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Primaquine Sales Market Share by Application (2017-2022)

Table 42. APAC Primaquine Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Primaquine Sales Market Share by Region (2017-2022)

Table 44. APAC Primaquine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Primaquine Revenue Market Share by Region (2017-2022)

Table 46. APAC Primaquine Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Primaquine Sales Market Share by Type (2017-2022)

Table 48. APAC Primaquine Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Primaquine Sales Market Share by Application (2017-2022)

Table 50. Europe Primaquine Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Primaquine Sales Market Share by Country (2017-2022)

Table 52. Europe Primaquine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Primaquine Revenue Market Share by Country (2017-2022)

Table 54. Europe Primaquine Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Primaquine Sales Market Share by Type (2017-2022)

Table 56. Europe Primaquine Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Primaquine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Primaquine Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Primaquine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Primaquine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Primaquine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Primaquine Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Primaquine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Primaquine Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Primaquine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Primaquine

Table 67. Key Market Challenges & Risks of Primaquine

Table 68. Key Industry Trends of Primaquine

Table 69. Primaquine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Primaquine Distributors List

Table 72. Primaquine Customer List

Table 73. Global Primaquine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Primaquine Sales Market Forecast by Region

Table 75. Global Primaquine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Primaquine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Primaquine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Primaquine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Primaquine Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Primaquine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Primaquine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Primaquine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Primaquine Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Primaquine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Primaquine Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Primaquine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Primaquine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Primaquine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Primaquine Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Primaquine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Primaquine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Primaquine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Cyper Pharma Basic Information, Primaquine Manufacturing Base, Sales Area and Its Competitors

Table 94. Cyper Pharma Primaquine Product Offered

Table 95. Cyper Pharma Primaquine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Cyper Pharma Main Business

Table 97. Cyper Pharma Latest Developments

Table 98. Santa Cruz Biotechnology Basic Information, Primaquine Manufacturing Base, Sales Area and Its Competitors

Table 99. Santa Cruz Biotechnology Primaquine Product Offered

Table 100. Santa Cruz Biotechnology Primaquine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Santa Cruz Biotechnology Main Business

Table 102. Santa Cruz Biotechnology Latest Developments

Table 103. Pfizer Basic Information, Primaquine Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Primaquine Product Offered

Table 105. Pfizer Primaquine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Summit Medical Group Basic Information, Primaquine Manufacturing Base, Sales Area and Its Competitors

Table 109. Summit Medical Group Primaquine Product Offered

Table 110. Summit Medical Group Primaquine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Summit Medical Group Main Business

Table 112. Summit Medical Group Latest Developments

List of Figures

Figure 1. Picture of Primaquine

Figure 2. Primaquine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Primaquine Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Primaquine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Primaquine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Injectables Primaquine

Figure 10. Product Picture of Capsules Primaquine

Figure 11. Product Picture of Tablets Primaquine

Figure 12. Global Primaquine Sales Market Share by Type in 2021

Figure 13. Global Primaquine Revenue Market Share by Type (2017-2022)

Figure 14. Primaquine Consumed in Hospital

Figure 15. Global Primaquine Market: Hospital (2017-2022) & (K Pcs)

Figure 16. Primaquine Consumed in Clinic

Figure 17. Global Primaquine Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Primaquine Consumed in Laboratory

Figure 19. Global Primaquine Market: Laboratory (2017-2022) & (K Pcs)

Figure 20. Primaquine Consumed in Others

Figure 21. Global Primaquine Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Primaquine Sales Market Share by Application (2017-2022)

Figure 23. Global Primaquine Revenue Market Share by Application in 2021

Figure 24. Primaquine Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Primaquine Revenue Market Share by Company in 2021

Figure 26. Global Primaquine Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Primaquine Revenue Market Share by Geographic Region in 2021

Figure 28. Global Primaquine Sales Market Share by Region (2017-2022)

Figure 29. Global Primaquine Revenue Market Share by Country/Region in 2021

Figure 30. Americas Primaquine Sales 2017-2022 (K Pcs)

Figure 31. Americas Primaquine Revenue 2017-2022 ($ Millions)

Figure 32. APAC Primaquine Sales 2017-2022 (K Pcs)

Figure 33. APAC Primaquine Revenue 2017-2022 ($ Millions)

Figure 34. Europe Primaquine Sales 2017-2022 (K Pcs)

Figure 35. Europe Primaquine Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Primaquine Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Primaquine Revenue 2017-2022 ($ Millions)

Figure 38. Americas Primaquine Sales Market Share by Country in 2021

Figure 39. Americas Primaquine Revenue Market Share by Country in 2021

Figure 40. United States Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Primaquine Sales Market Share by Region in 2021

Figure 45. APAC Primaquine Revenue Market Share by Regions in 2021

Figure 46. China Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Primaquine Sales Market Share by Country in 2021

Figure 53. Europe Primaquine Revenue Market Share by Country in 2021

Figure 54. Germany Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Primaquine Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Primaquine Revenue Market Share by Country in 2021

Figure 61. Egypt Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Primaquine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Primaquine in 2021

Figure 67. Manufacturing Process Analysis of Primaquine

Figure 68. Industry Chain Structure of Primaquine

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390